Thomas Kislinger
Impact in
- Clinical Biochemistry top 0.02%
- Advanced Glycation End Products research
- Cancer Research top 1%
- MicroRNA in disease regulation
Papers in
-
- Extracellular vesicles in disease 15
- RNA modifications and cancer 13
- Metabolomics and Mass Spectrometry Studies 12
- Ubiquitin and proteasome pathways 8
- Glycosylation and Glycoproteins Research 8
- Spectroscopy 57
- Advanced Proteomics Techniques and Applications 56
- Mass Spectrometry Techniques and Applications 31
- Co-authors
- Ann Marie Schmidt (10 shared papers)David M. Stern (9 shared papers)Andrew Emili (19 shared papers)Wu Qu (8 shared papers)Anthony O. Gramolini (29 shared papers)Caifeng Fu (4 shared papers)Monika Pischetsrieder (12 shared papers)Vladimir Ignatchenko (45 shared papers)
- Journals
- Journal of Proteome Research (19 papers)Molecular & Cellular Proteomics (8 papers)Nature Communications (8 papers)PROTEOMICS (7 papers)PLoS ONE (4 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Thomas Kislinger
165 papers receiving 11.6k citations
Thomas Kislinger's Hit Papers
Peers
Comparison fields: 5 of 155
- Clinical Biochemistry 3.5k
- Cancer Research 1.4k
- Endocrinology, Diabetes and Metabolism 1.3k
- Spectroscopy 1.5k
- Molecular Biology 5.4k
Countries citing papers authored by Thomas Kislinger
This map shows the geographic impact of Thomas Kislinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kislinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kislinger more than expected).
Fields of papers citing papers by Thomas Kislinger
This network shows the impact of papers produced by Thomas Kislinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kislinger. The network helps show where Thomas Kislinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Kislinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 172 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases Hit paper breakdown → | 2000 | 1059 |
| 2 | N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression Hit paper breakdown → | 1999 | 763 |
| 3 | Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions Hit paper breakdown → | 2003 | 621 |
| 4 | 2003 | 486 | |
| 5 | 2002 | 481 | |
| 6 | 2002 | 458 | |
| 7 | 2000 | 399 | |
| 8 | 2006 | 378 | |
| 9 | 2001 | 360 | |
| 10 | 2000 | 305 | |
| 11 | 2014 | 250 | |
| 12 | 2001 | 237 | |
| 13 | 2020 | 220 | |
| 14 | 2014 | 169 | |
| 15 | 2005 | 146 | |
| 16 | 2013 | 138 | |
| 17 | 2003 | 135 | |
| 18 | 2007 | 124 | |
| 19 | 2012 | 121 | |
| 20 | 2009 | 120 |
About Thomas Kislinger
Thomas Kislinger is a scholar working on Molecular Biology, Spectroscopy, Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 172 papers that have together received 11.8k indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (56 papers), Mass Spectrometry Techniques and Applications (31 papers), Advanced Glycation End Products research (16 papers), Extracellular vesicles in disease (15 papers), RNA modifications and cancer (13 papers), Metabolomics and Mass Spectrometry Studies (12 papers), Ubiquitin and proteasome pathways (8 papers) and Glycosylation and Glycoproteins Research (8 papers). The work is most often cited by research in Clinical Biochemistry (3.5k citations), Cancer Research (1.4k citations), Endocrinology, Diabetes and Metabolism (1.3k citations), Spectroscopy (1.5k citations) and Molecular Biology (5.4k citations). Thomas Kislinger has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Ann Marie Schmidt, David M. Stern, Andrew Emili, Wu Qu, Anthony O. Gramolini, Caifeng Fu, Monika Pischetsrieder, Vladimir Ignatchenko, M. Hofmann and Yan Lü. Their work appears in journals such as Journal of Proteome Research, Molecular & Cellular Proteomics, Nature Communications, PROTEOMICS and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.